EMERYVILLE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
Tesla's ability to outrage and inspire may seem novel to some but the vehicle may be a spiritual kin with another scorned ...
Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...
“We have already worked with a local primary school to design our new logo which I hope will be shared and recognised widely. “We are working closely with partners to disrupt criminal networks that ...
Qatar Incas Pathanamthitta District Youth Wing organised an anti-drug campaign with the theme ‘Say No To Drugs, Say Yes To Life’. Incas president Hyder Chungathara inaugurated the programme.
Shimla: Health Minister Dhani Ram Shandil on Wednesday introduced the Himachal Pradesh Drugs and Controlled Substance (Prevention, De-addiction and Rehabilitation) Bill, 2025. The proposed law is ...
In a state where top college athletes become household names, he's enlisting some of them to deliver positive, anti-drug ...
The CM said the government will coordinate with the public and various departments to shape up a strong campaign against drugs. "By merging various ongoing campaigns, a strong anti-drug campaign ...
In a state where top college athletes become household names, he's enlisting some of them to deliver positive, anti-drug messages. “To reach Kentucky’s young people with an effective statewide ...
KOCHI: An anti-drugs campaigner was attacked by a 36-year-old man at Thuthiyoor near Kakkanad on Monday. The victim, Babu Antony, a resident of Thuthiyoor, is a state council member of the Kerala ...
(Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro (tirzepatide) in India. Priced at Rs 14,000 for a 2.5 mg monthly dose (Rs ...
A drug-resistant type of bacteria that has adapted ... That means we may soon have only one single target for which to design therapeutics such as antibiotics or phage therapy," Van Tyne said.